Kiyoshi Kita spends much of his time researching Biochemistry, Mitochondrion, Respiratory chain, Cytochrome and Enzyme. Kiyoshi Kita frequently studies issues relating to Ascaris suum and Biochemistry. His Mitochondrion study combines topics in areas such as Oxidative phosphorylation, Plasmodium and Transfer RNA.
His biological study spans a wide range of topics, including Fumarate reductase, NADH dehydrogenase, Microbiology, COQ7 and Mitochondrial biogenesis. His work carried out in the field of Cytochrome brings together such families of science as Electron Transport Complex II, Cytochrome d, Gel electrophoresis and Heme. The study incorporates disciplines such as Lipid metabolism and Serum albumin in addition to Enzyme.
Kiyoshi Kita focuses on Biochemistry, Mitochondrion, Respiratory chain, Enzyme and Molecular biology. In his study, which falls under the umbrella issue of Biochemistry, Protein subunit is strongly linked to Ascaris suum. His research in Mitochondrion focuses on subjects like Plasmodium falciparum, which are connected to Cell biology, Virology and Microbiology.
The various areas that Kiyoshi Kita examines in his Respiratory chain study include Ascaris and NADH dehydrogenase. His study focuses on the intersection of Enzyme and fields such as Escherichia coli with connections in the field of Recombinant DNA. His Molecular biology research is multidisciplinary, relying on both Complementary DNA, Peptide sequence, Gene and Amino acid.
Kiyoshi Kita mainly investigates Biochemistry, Plasmodium falciparum, Microbiology, Pharmacology and Alternative oxidase. Dihydroorotate dehydrogenase, Enzyme, Mitochondrion, Glycerol kinase and In vitro are the subjects of his Biochemistry studies. Mitochondrion is a subfield of Cell biology that Kiyoshi Kita tackles.
His Microbiology research includes elements of Molecular biology, Cerebral Malaria, Fungus and Plasmodium berghei. His Pharmacology research is multidisciplinary, incorporating perspectives in Trypanosoma cruzi, Chagas disease and In vivo. His research integrates issues of Ubiquinol, Trypanosoma brucei and Drug design in his study of Alternative oxidase.
His primary scientific interests are in Biochemistry, Ascofuranone, Chagas disease, Pharmacology and Plasmodium falciparum. His works in Enzyme, Alternative oxidase, Dihydroorotate dehydrogenase, Respiratory chain and Transferase are all subjects of inquiry into Biochemistry. His Alternative oxidase study integrates concerns from other disciplines, such as Potency, Trypanosoma brucei, Site-directed mutagenesis and Ubiquinol oxidase, Escherichia coli.
His Respiratory chain study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno;Jeremy N. Burrows;Ken Duncan;Rob Hooft van Huijsduijnen.
Nature Reviews Drug Discovery (2015)
Terminal oxidases of Escherichia coli aerobic respiratory chain. I. Purification and properties of cytochrome b562-o complex from cells in the early exponential phase of aerobic growth.
K Kita;K Konishi;Y Anraku.
Journal of Biological Chemistry (1984)
Terminal oxidases of Escherichia coli aerobic respiratory chain. II. Purification and properties of cytochrome b558-d complex from cells grown with limited oxygen and evidence of branched electron-carrying systems.
K Kita;K Konishi;Y Anraku.
Journal of Biological Chemistry (1984)
Spread and evolution of Plasmodium falciparum drug resistance
Toshihiro Mita;Kazuyuki Tanabe;Kiyoshi Kita.
Parasitology International (2009)
Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase)
Hiroko Miyadera;Kazuro Shiomi;Hideaki Ui;Yuichi Yamaguchi.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Altered Quinone Biosynthesis in the Long-lived clk-1Mutants of Caenorhabditis elegans
Hiroko Miyadera;Hisako Amino;Akira Hiraishi;Hikari Taka.
Journal of Biological Chemistry (2001)
Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade
Shin Ichiro Tachibana;Steven A. Sullivan;Satoru Kawai;Shota Nakamura.
Nature Genetics (2012)
Structure of the trypanosome cyanide-insensitive alternative oxidase
Tomoo Shiba;Yasutoshi Kido;Kimitoshi Sakamoto;Daniel Ken Inaoka.
Proceedings of the National Academy of Sciences of the United States of America (2013)
An anthelmintic compound, nafuredin, shows selective inhibition of complex I in helminth mitochondria
Satoshi Ōmura;Hiroko Miyadera;Hideaki Ui;Kazuro Shiomi.
Proceedings of the National Academy of Sciences of the United States of America (2001)
One-step purification from Escherichia coli of complex II (succinate: ubiquinone oxidoreductase) associated with succinate-reducible cytochrome b556.
K. Kita;C. R. T. Vibat;S. Meinhardt;J. R. Guest.
Journal of Biological Chemistry (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Tokyo Medical and Dental University
Kitasato University
Chubu University
University of Tokyo
Kitasato University
University of Tokyo
Osaka University
University of Edinburgh
University of Tokyo
Kitasato University
National Institute of Advanced Industrial Science and Technology
Publications: 26
DONNELLY CORPORATION
National Institute of Technology Rourkela
University of Bordeaux
Nanyang Technological University
University of California, Los Angeles
APEX Think Consulting
Purdue University West Lafayette
Oklahoma State University
University of Warwick
Washington University in St. Louis
University of Illinois at Chicago
Claude Bernard University Lyon 1
University of Pittsburgh
Vrije Universiteit Amsterdam
Cardiff University
University of Toronto